Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.9M Buy
8,530
+4,096
+92% +$744K 0.02% 520
2026
Q1
$681K Buy
4,434
+1,711
+63% +$232K 0.01% 759
2025
Q4
$309K Buy
2,723
+229
+9% +$27.8K ﹤0.01% 991
2025
Q3
$331K Sell
2,494
-597
-19% -$82K 0.01% 973
2025
Q2
$438K Buy
3,091
+833
+37% +$118K 0.01% 861
2025
Q1
$343K Sell
2,258
-2,087
-48% -$328K 0.01% 898
2024
Q4
$650K Buy
4,345
+2,340
+117% +$367K 0.01% 720
2024
Q3
$277K Sell
2,005
-183
-8% -$27K 0.01% 901
2024
Q2
$303K Buy
2,188
+183
+9% +$25.2K 0.01% 906
2024
Q1
$277K Sell
2,005
-211
-10% -$25.3K 0.01% 899
2023
Q4
$232K Sell
2,216
-4,039
-65% -$373K 0.01% 949
2023
Q3
$591K Sell
6,255
-584
-9% -$59.6K 0.02% 626
2023
Q2
$687K Sell
6,839
-7,077
-51% -$657K 0.03% 555
2023
Q1
$1.13M Buy
13,916
+9,939
+250% +$796K 0.05% 420
2022
Q4
$297K Buy
3,977
+1,481
+59% +$115K 0.02% 721
2022
Q3
$207K Buy
+2,496
New +$219K 0.01% 735

Other funds holding DVA

Ethic Inc's DVA Position: Q2 2026 in Review

Ethic Inc increased its DaVita (DVA) stake by 92% in Q2 2026, buying an estimated $744K and bringing the position to 8,530 shares worth $1.9M. The position accounts for 0.02% of the portfolio, ranked #520.

Ethic Inc first reported a position in DVA in Q3 2022 and has held it in 16 quarters since. 185 funds tracked by Wall St. Rank hold DVA as of Q2 2026.

  • Ethic Inc held 8,530 shares of DaVita worth $1.9M as of Q2 2026.
  • Ethic Inc bought 4,096 DaVita shares in Q2 2026, an estimated $744K.
  • DaVita made up 0.02% of Ethic Inc's portfolio in Q2 2026, its #520 holding.
  • Ethic Inc first reported a position in DaVita in Q3 2022 and has held it in 16 quarters since.
  • 185 funds tracked by Wall St. Rank held DaVita as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.